With regards to this, it has been reported that breast cancer cell lines with a triple-negative (ER negative, PR negative and HER-2 negative) molecular profile exhibit enhanced expression and activity of p38 MAPK, which has been correlated with poor prognosis and survival in patients [25]. This evidence concerns the gene ERBB2 and breast cancer.